Constantly condensing the truth
The Scientific Advisory Board will assist the company in evaluating its product development and make recommendations to the company
Development strategy/pipeline deployment/production process to give professional evaluation/advice/decision.
In July 2022, he joined Shanghai Lishan Biomedicine Co., LTD
Professor researcher, doctoral supervisor, Executive Vice President of the Institute of Cross Science, Shanghai University of Traditional Chinese Medicine
National Outstanding youth, National Young Qhuang Scholar, Shanghai outstanding academic leader.
Main research interests: Efficient discovery and druggability optimization of enzyme inhibitors derived from nature. It has successively been in J Am Chem Soc, Angew Chem Int Ed, Chem Sci, Biosens Bioelectron, Coordin Chem Rev, Trends Anal Chem, J Med Chem, Acta Another 240 SCI papers with an H-factor of 42 have been published in international academic journals such as Pharmaceutica Sinica B, with a total of 5300 citations. He has presided over more than 10 major scientific research projects at the national and provincial levels. He has won the Chinese Pharmaceutical Society - Yiling Biomedicine Youth Award, the Chinese Society of Traditional Chinese Medicine Young and Middle-aged Innovative Talent Award, the first Young Qhuang Scholar, Shanghai Youth May Fourth Medal and other honors, and was selected to the world's 2% top scientists list (pharmacy).
Shanghai Public Network Anbei 31011502402974